nodes	percent_of_prediction	percent_of_DWPC	metapath
Perflutren—Sweating increased—Pravastatin—atherosclerosis	0.00478	0.00481	CcSEcCtD
Perflutren—Neuropathy peripheral—Simvastatin—atherosclerosis	0.00475	0.00477	CcSEcCtD
Perflutren—Sevoflurane—ALB—atherosclerosis	0.00465	1	CrCbGaD
Perflutren—Pharyngitis—Ezetimibe—atherosclerosis	0.00453	0.00455	CcSEcCtD
Perflutren—Connective tissue disorder—Ezetimibe—atherosclerosis	0.00448	0.0045	CcSEcCtD
Perflutren—Angioedema—Rosuvastatin—atherosclerosis	0.00436	0.00438	CcSEcCtD
Perflutren—Flushing—Lovastatin—atherosclerosis	0.00431	0.00433	CcSEcCtD
Perflutren—Neuropathy peripheral—Pravastatin—atherosclerosis	0.00429	0.00431	CcSEcCtD
Perflutren—Flushing—Ezetimibe—atherosclerosis	0.00423	0.00425	CcSEcCtD
Perflutren—Chills—Lovastatin—atherosclerosis	0.00417	0.00419	CcSEcCtD
Perflutren—Cough—Rosuvastatin—atherosclerosis	0.00417	0.00419	CcSEcCtD
Perflutren—Angiopathy—Ezetimibe—atherosclerosis	0.00414	0.00416	CcSEcCtD
Perflutren—Immune system disorder—Ezetimibe—atherosclerosis	0.00412	0.00414	CcSEcCtD
Perflutren—Mediastinal disorder—Ezetimibe—atherosclerosis	0.00411	0.00413	CcSEcCtD
Perflutren—Myalgia—Rosuvastatin—atherosclerosis	0.00407	0.00408	CcSEcCtD
Perflutren—Arthralgia—Rosuvastatin—atherosclerosis	0.00407	0.00408	CcSEcCtD
Perflutren—Flushing—Simvastatin—atherosclerosis	0.00404	0.00405	CcSEcCtD
Perflutren—Haemoglobin—Niacin—atherosclerosis	0.00401	0.00403	CcSEcCtD
Perflutren—Rhinitis—Niacin—atherosclerosis	0.004	0.00402	CcSEcCtD
Perflutren—Haemorrhage—Niacin—atherosclerosis	0.00399	0.00401	CcSEcCtD
Perflutren—Hypoaesthesia—Niacin—atherosclerosis	0.00397	0.00399	CcSEcCtD
Perflutren—Erythema—Ezetimibe—atherosclerosis	0.00397	0.00399	CcSEcCtD
Perflutren—Dysgeusia—Lovastatin—atherosclerosis	0.00396	0.00398	CcSEcCtD
Perflutren—Rhinitis—Pravastatin—atherosclerosis	0.00394	0.00396	CcSEcCtD
Perflutren—Back pain—Lovastatin—atherosclerosis	0.00391	0.00393	CcSEcCtD
Perflutren—Hypoaesthesia—Pravastatin—atherosclerosis	0.00391	0.00393	CcSEcCtD
Perflutren—Pharyngitis—Pravastatin—atherosclerosis	0.0039	0.00392	CcSEcCtD
Perflutren—Chills—Simvastatin—atherosclerosis	0.0039	0.00392	CcSEcCtD
Perflutren—Muscle spasms—Lovastatin—atherosclerosis	0.00389	0.00391	CcSEcCtD
Perflutren—Visual impairment—Niacin—atherosclerosis	0.00385	0.00387	CcSEcCtD
Perflutren—Back pain—Ezetimibe—atherosclerosis	0.00384	0.00386	CcSEcCtD
Perflutren—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00382	0.00384	CcSEcCtD
Perflutren—Muscle spasms—Ezetimibe—atherosclerosis	0.00382	0.00383	CcSEcCtD
Perflutren—Vision blurred—Lovastatin—atherosclerosis	0.00381	0.00383	CcSEcCtD
Perflutren—Tremor—Lovastatin—atherosclerosis	0.00379	0.00381	CcSEcCtD
Perflutren—Visual impairment—Pravastatin—atherosclerosis	0.00379	0.00381	CcSEcCtD
Perflutren—Erythema—Simvastatin—atherosclerosis	0.00379	0.0038	CcSEcCtD
Perflutren—Ill-defined disorder—Lovastatin—atherosclerosis	0.00375	0.00377	CcSEcCtD
Perflutren—Eye disorder—Niacin—atherosclerosis	0.00373	0.00375	CcSEcCtD
Perflutren—Tinnitus—Niacin—atherosclerosis	0.00372	0.00374	CcSEcCtD
Perflutren—Dysgeusia—Simvastatin—atherosclerosis	0.00371	0.00372	CcSEcCtD
Perflutren—Flushing—Niacin—atherosclerosis	0.00371	0.00372	CcSEcCtD
Perflutren—Angioedema—Lovastatin—atherosclerosis	0.0037	0.00371	CcSEcCtD
Perflutren—Ill-defined disorder—Ezetimibe—atherosclerosis	0.00368	0.0037	CcSEcCtD
Perflutren—Tinnitus—Pravastatin—atherosclerosis	0.00367	0.00368	CcSEcCtD
Perflutren—Malaise—Lovastatin—atherosclerosis	0.00365	0.00367	CcSEcCtD
Perflutren—Flushing—Pravastatin—atherosclerosis	0.00365	0.00367	CcSEcCtD
Perflutren—Cardiac disorder—Pravastatin—atherosclerosis	0.00365	0.00367	CcSEcCtD
Perflutren—Muscle spasms—Simvastatin—atherosclerosis	0.00364	0.00366	CcSEcCtD
Perflutren—Vertigo—Lovastatin—atherosclerosis	0.00364	0.00365	CcSEcCtD
Perflutren—Angioedema—Ezetimibe—atherosclerosis	0.00363	0.00364	CcSEcCtD
Perflutren—Angiopathy—Niacin—atherosclerosis	0.00362	0.00364	CcSEcCtD
Perflutren—Leukopenia—Lovastatin—atherosclerosis	0.00362	0.00364	CcSEcCtD
Perflutren—Chills—Niacin—atherosclerosis	0.00358	0.0036	CcSEcCtD
Perflutren—Malaise—Ezetimibe—atherosclerosis	0.00358	0.0036	CcSEcCtD
Perflutren—Vision blurred—Simvastatin—atherosclerosis	0.00357	0.00358	CcSEcCtD
Perflutren—Arrhythmia—Niacin—atherosclerosis	0.00357	0.00358	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00355	0.00357	CcSEcCtD
Perflutren—Tremor—Simvastatin—atherosclerosis	0.00355	0.00356	CcSEcCtD
Perflutren—Chills—Pravastatin—atherosclerosis	0.00353	0.00354	CcSEcCtD
Perflutren—Ill-defined disorder—Simvastatin—atherosclerosis	0.00351	0.00353	CcSEcCtD
Perflutren—Arrhythmia—Pravastatin—atherosclerosis	0.00351	0.00353	CcSEcCtD
Perflutren—Palpitations—Ezetimibe—atherosclerosis	0.00351	0.00352	CcSEcCtD
Perflutren—Paraesthesia—Rosuvastatin—atherosclerosis	0.0035	0.00352	CcSEcCtD
Perflutren—Erythema—Niacin—atherosclerosis	0.00348	0.00349	CcSEcCtD
Perflutren—Cough—Ezetimibe—atherosclerosis	0.00346	0.00348	CcSEcCtD
Perflutren—Angioedema—Simvastatin—atherosclerosis	0.00346	0.00347	CcSEcCtD
Perflutren—Myalgia—Lovastatin—atherosclerosis	0.00345	0.00346	CcSEcCtD
Perflutren—Arthralgia—Lovastatin—atherosclerosis	0.00345	0.00346	CcSEcCtD
Perflutren—Chest pain—Lovastatin—atherosclerosis	0.00345	0.00346	CcSEcCtD
Perflutren—Dyspepsia—Rosuvastatin—atherosclerosis	0.00343	0.00345	CcSEcCtD
Perflutren—Hypertension—Ezetimibe—atherosclerosis	0.00343	0.00344	CcSEcCtD
Perflutren—Malaise—Simvastatin—atherosclerosis	0.00341	0.00343	CcSEcCtD
Perflutren—Discomfort—Lovastatin—atherosclerosis	0.0034	0.00342	CcSEcCtD
Perflutren—Vertigo—Simvastatin—atherosclerosis	0.0034	0.00342	CcSEcCtD
Perflutren—Leukopenia—Simvastatin—atherosclerosis	0.00339	0.0034	CcSEcCtD
Perflutren—Chest pain—Ezetimibe—atherosclerosis	0.00338	0.00339	CcSEcCtD
Perflutren—Myalgia—Ezetimibe—atherosclerosis	0.00338	0.00339	CcSEcCtD
Perflutren—Arthralgia—Ezetimibe—atherosclerosis	0.00338	0.00339	CcSEcCtD
Perflutren—Dry mouth—Lovastatin—atherosclerosis	0.00337	0.00339	CcSEcCtD
Perflutren—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.00336	0.00337	CcSEcCtD
Perflutren—Dysgeusia—Pravastatin—atherosclerosis	0.00335	0.00337	CcSEcCtD
Perflutren—Muscle spasms—Niacin—atherosclerosis	0.00334	0.00336	CcSEcCtD
Perflutren—Discomfort—Ezetimibe—atherosclerosis	0.00334	0.00335	CcSEcCtD
Perflutren—Pain—Rosuvastatin—atherosclerosis	0.00333	0.00335	CcSEcCtD
Perflutren—Dry mouth—Ezetimibe—atherosclerosis	0.0033	0.00332	CcSEcCtD
Perflutren—Anaphylactic shock—Lovastatin—atherosclerosis	0.0033	0.00332	CcSEcCtD
Perflutren—Muscle spasms—Pravastatin—atherosclerosis	0.00329	0.00331	CcSEcCtD
Perflutren—Vision blurred—Niacin—atherosclerosis	0.00328	0.00329	CcSEcCtD
Perflutren—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00324	0.00325	CcSEcCtD
Perflutren—Vision blurred—Pravastatin—atherosclerosis	0.00323	0.00324	CcSEcCtD
Perflutren—Arthralgia—Simvastatin—atherosclerosis	0.00322	0.00324	CcSEcCtD
Perflutren—Myalgia—Simvastatin—atherosclerosis	0.00322	0.00324	CcSEcCtD
Perflutren—Chest pain—Simvastatin—atherosclerosis	0.00322	0.00324	CcSEcCtD
Perflutren—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00321	0.00323	CcSEcCtD
Perflutren—Tremor—Pravastatin—atherosclerosis	0.00321	0.00322	CcSEcCtD
Perflutren—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00319	0.0032	CcSEcCtD
Perflutren—Discomfort—Simvastatin—atherosclerosis	0.00318	0.0032	CcSEcCtD
Perflutren—Nervous system disorder—Ezetimibe—atherosclerosis	0.00318	0.00319	CcSEcCtD
Perflutren—Angioedema—Niacin—atherosclerosis	0.00318	0.00319	CcSEcCtD
Perflutren—Ill-defined disorder—Pravastatin—atherosclerosis	0.00318	0.00319	CcSEcCtD
Perflutren—Skin disorder—Ezetimibe—atherosclerosis	0.00315	0.00316	CcSEcCtD
Perflutren—Angioedema—Pravastatin—atherosclerosis	0.00313	0.00314	CcSEcCtD
Perflutren—Vertigo—Niacin—atherosclerosis	0.00312	0.00314	CcSEcCtD
Perflutren—Syncope—Niacin—atherosclerosis	0.00312	0.00313	CcSEcCtD
Perflutren—Leukopenia—Niacin—atherosclerosis	0.00311	0.00313	CcSEcCtD
Perflutren—Urticaria—Rosuvastatin—atherosclerosis	0.0031	0.00311	CcSEcCtD
Perflutren—Oedema—Simvastatin—atherosclerosis	0.00309	0.0031	CcSEcCtD
Perflutren—Anaphylactic shock—Simvastatin—atherosclerosis	0.00309	0.0031	CcSEcCtD
Perflutren—Malaise—Pravastatin—atherosclerosis	0.00309	0.0031	CcSEcCtD
Perflutren—Abdominal pain—Rosuvastatin—atherosclerosis	0.00308	0.0031	CcSEcCtD
Perflutren—Vertigo—Pravastatin—atherosclerosis	0.00307	0.00309	CcSEcCtD
Perflutren—Palpitations—Niacin—atherosclerosis	0.00307	0.00309	CcSEcCtD
Perflutren—Leukopenia—Pravastatin—atherosclerosis	0.00306	0.00308	CcSEcCtD
Perflutren—Loss of consciousness—Niacin—atherosclerosis	0.00305	0.00307	CcSEcCtD
Perflutren—Cough—Niacin—atherosclerosis	0.00303	0.00305	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00301	0.00302	CcSEcCtD
Perflutren—Cough—Pravastatin—atherosclerosis	0.00299	0.003	CcSEcCtD
Perflutren—Paraesthesia—Lovastatin—atherosclerosis	0.00297	0.00298	CcSEcCtD
Perflutren—Arthralgia—Niacin—atherosclerosis	0.00296	0.00297	CcSEcCtD
Perflutren—Myalgia—Niacin—atherosclerosis	0.00296	0.00297	CcSEcCtD
Perflutren—Hypertension—Pravastatin—atherosclerosis	0.00295	0.00297	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00295	0.00297	CcSEcCtD
Perflutren—Dyspnoea—Lovastatin—atherosclerosis	0.00294	0.00296	CcSEcCtD
Perflutren—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.00294	0.00295	CcSEcCtD
Perflutren—Arthralgia—Pravastatin—atherosclerosis	0.00291	0.00293	CcSEcCtD
Perflutren—Chest pain—Pravastatin—atherosclerosis	0.00291	0.00293	CcSEcCtD
Perflutren—Myalgia—Pravastatin—atherosclerosis	0.00291	0.00293	CcSEcCtD
Perflutren—Paraesthesia—Ezetimibe—atherosclerosis	0.00291	0.00292	CcSEcCtD
Perflutren—Dyspepsia—Lovastatin—atherosclerosis	0.00291	0.00292	CcSEcCtD
Perflutren—Dry mouth—Niacin—atherosclerosis	0.00289	0.00291	CcSEcCtD
Perflutren—Dyspnoea—Ezetimibe—atherosclerosis	0.00289	0.0029	CcSEcCtD
Perflutren—Discomfort—Pravastatin—atherosclerosis	0.00288	0.00289	CcSEcCtD
Perflutren—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00287	0.00288	CcSEcCtD
Perflutren—Dyspepsia—Ezetimibe—atherosclerosis	0.00285	0.00286	CcSEcCtD
Perflutren—Fatigue—Lovastatin—atherosclerosis	0.00285	0.00286	CcSEcCtD
Perflutren—Anaphylactic shock—Niacin—atherosclerosis	0.00284	0.00285	CcSEcCtD
Perflutren—Oedema—Niacin—atherosclerosis	0.00284	0.00285	CcSEcCtD
Perflutren—Pain—Lovastatin—atherosclerosis	0.00282	0.00284	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00281	0.00283	CcSEcCtD
Perflutren—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.0028	0.00281	CcSEcCtD
Perflutren—Asthenia—Rosuvastatin—atherosclerosis	0.0028	0.00281	CcSEcCtD
Perflutren—Anaphylactic shock—Pravastatin—atherosclerosis	0.00279	0.00281	CcSEcCtD
Perflutren—Oedema—Pravastatin—atherosclerosis	0.00279	0.00281	CcSEcCtD
Perflutren—Fatigue—Ezetimibe—atherosclerosis	0.00279	0.00281	CcSEcCtD
Perflutren—Shock—Niacin—atherosclerosis	0.00279	0.0028	CcSEcCtD
Perflutren—Paraesthesia—Simvastatin—atherosclerosis	0.00277	0.00279	CcSEcCtD
Perflutren—Pain—Ezetimibe—atherosclerosis	0.00277	0.00278	CcSEcCtD
Perflutren—Tachycardia—Niacin—atherosclerosis	0.00277	0.00278	CcSEcCtD
Perflutren—Pruritus—Rosuvastatin—atherosclerosis	0.00276	0.00277	CcSEcCtD
Perflutren—Skin disorder—Niacin—atherosclerosis	0.00276	0.00277	CcSEcCtD
Perflutren—Dyspnoea—Simvastatin—atherosclerosis	0.00275	0.00277	CcSEcCtD
Perflutren—Hyperhidrosis—Niacin—atherosclerosis	0.00274	0.00275	CcSEcCtD
Perflutren—Feeling abnormal—Lovastatin—atherosclerosis	0.00272	0.00273	CcSEcCtD
Perflutren—Dyspepsia—Simvastatin—atherosclerosis	0.00272	0.00273	CcSEcCtD
Perflutren—Gastrointestinal pain—Lovastatin—atherosclerosis	0.0027	0.00271	CcSEcCtD
Perflutren—Hyperhidrosis—Pravastatin—atherosclerosis	0.0027	0.00271	CcSEcCtD
Perflutren—Feeling abnormal—Ezetimibe—atherosclerosis	0.00267	0.00268	CcSEcCtD
Perflutren—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00267	0.00268	CcSEcCtD
Perflutren—Diarrhoea—Rosuvastatin—atherosclerosis	0.00267	0.00268	CcSEcCtD
Perflutren—Fatigue—Simvastatin—atherosclerosis	0.00266	0.00268	CcSEcCtD
Perflutren—Hypotension—Niacin—atherosclerosis	0.00265	0.00266	CcSEcCtD
Perflutren—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00265	0.00266	CcSEcCtD
Perflutren—Pain—Simvastatin—atherosclerosis	0.00264	0.00265	CcSEcCtD
Perflutren—Urticaria—Lovastatin—atherosclerosis	0.00262	0.00264	CcSEcCtD
Perflutren—Body temperature increased—Lovastatin—atherosclerosis	0.00261	0.00262	CcSEcCtD
Perflutren—Abdominal pain—Lovastatin—atherosclerosis	0.00261	0.00262	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00258	0.0026	CcSEcCtD
Perflutren—Dizziness—Rosuvastatin—atherosclerosis	0.00258	0.00259	CcSEcCtD
Perflutren—Urticaria—Ezetimibe—atherosclerosis	0.00257	0.00259	CcSEcCtD
Perflutren—Body temperature increased—Ezetimibe—atherosclerosis	0.00256	0.00257	CcSEcCtD
Perflutren—Abdominal pain—Ezetimibe—atherosclerosis	0.00256	0.00257	CcSEcCtD
Perflutren—Paraesthesia—Niacin—atherosclerosis	0.00255	0.00256	CcSEcCtD
Perflutren—Feeling abnormal—Simvastatin—atherosclerosis	0.00255	0.00256	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.00254	0.00256	CcSEcCtD
Perflutren—Dyspnoea—Niacin—atherosclerosis	0.00253	0.00254	CcSEcCtD
Perflutren—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00253	0.00254	CcSEcCtD
Perflutren—Paraesthesia—Pravastatin—atherosclerosis	0.00251	0.00252	CcSEcCtD
Perflutren—Dyspepsia—Niacin—atherosclerosis	0.0025	0.00251	CcSEcCtD
Perflutren—Dyspnoea—Pravastatin—atherosclerosis	0.00249	0.0025	CcSEcCtD
Perflutren—Dyspepsia—Pravastatin—atherosclerosis	0.00246	0.00247	CcSEcCtD
Perflutren—Rash—Rosuvastatin—atherosclerosis	0.00246	0.00247	CcSEcCtD
Perflutren—Dermatitis—Rosuvastatin—atherosclerosis	0.00245	0.00247	CcSEcCtD
Perflutren—Urticaria—Simvastatin—atherosclerosis	0.00245	0.00247	CcSEcCtD
Perflutren—Gastrointestinal disorder—Niacin—atherosclerosis	0.00245	0.00246	CcSEcCtD
Perflutren—Body temperature increased—Simvastatin—atherosclerosis	0.00244	0.00245	CcSEcCtD
Perflutren—Abdominal pain—Simvastatin—atherosclerosis	0.00244	0.00245	CcSEcCtD
Perflutren—Headache—Rosuvastatin—atherosclerosis	0.00244	0.00245	CcSEcCtD
Perflutren—Hypersensitivity—Lovastatin—atherosclerosis	0.00243	0.00244	CcSEcCtD
Perflutren—Pain—Niacin—atherosclerosis	0.00243	0.00244	CcSEcCtD
Perflutren—Fatigue—Pravastatin—atherosclerosis	0.00241	0.00242	CcSEcCtD
Perflutren—Pain—Pravastatin—atherosclerosis	0.00239	0.0024	CcSEcCtD
Perflutren—Hypersensitivity—Ezetimibe—atherosclerosis	0.00239	0.0024	CcSEcCtD
Perflutren—Asthenia—Lovastatin—atherosclerosis	0.00237	0.00238	CcSEcCtD
Perflutren—Pruritus—Lovastatin—atherosclerosis	0.00234	0.00235	CcSEcCtD
Perflutren—Asthenia—Ezetimibe—atherosclerosis	0.00232	0.00234	CcSEcCtD
Perflutren—Gastrointestinal pain—Niacin—atherosclerosis	0.00232	0.00233	CcSEcCtD
Perflutren—Nausea—Rosuvastatin—atherosclerosis	0.00231	0.00233	CcSEcCtD
Perflutren—Feeling abnormal—Pravastatin—atherosclerosis	0.0023	0.00231	CcSEcCtD
Perflutren—Pruritus—Ezetimibe—atherosclerosis	0.00229	0.0023	CcSEcCtD
Perflutren—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00228	0.00229	CcSEcCtD
Perflutren—Hypersensitivity—Simvastatin—atherosclerosis	0.00228	0.00229	CcSEcCtD
Perflutren—Diarrhoea—Lovastatin—atherosclerosis	0.00226	0.00227	CcSEcCtD
Perflutren—Urticaria—Niacin—atherosclerosis	0.00225	0.00226	CcSEcCtD
Perflutren—Abdominal pain—Niacin—atherosclerosis	0.00224	0.00225	CcSEcCtD
Perflutren—Body temperature increased—Niacin—atherosclerosis	0.00224	0.00225	CcSEcCtD
Perflutren—Urticaria—Pravastatin—atherosclerosis	0.00222	0.00223	CcSEcCtD
Perflutren—Asthenia—Simvastatin—atherosclerosis	0.00222	0.00223	CcSEcCtD
Perflutren—Diarrhoea—Ezetimibe—atherosclerosis	0.00222	0.00223	CcSEcCtD
Perflutren—Abdominal pain—Pravastatin—atherosclerosis	0.00221	0.00222	CcSEcCtD
Perflutren—Body temperature increased—Pravastatin—atherosclerosis	0.00221	0.00222	CcSEcCtD
Perflutren—Pruritus—Simvastatin—atherosclerosis	0.00219	0.0022	CcSEcCtD
Perflutren—Dizziness—Lovastatin—atherosclerosis	0.00218	0.00219	CcSEcCtD
Perflutren—Dizziness—Ezetimibe—atherosclerosis	0.00214	0.00215	CcSEcCtD
Perflutren—Diarrhoea—Simvastatin—atherosclerosis	0.00211	0.00212	CcSEcCtD
Perflutren—Vomiting—Lovastatin—atherosclerosis	0.0021	0.00211	CcSEcCtD
Perflutren—Hypersensitivity—Niacin—atherosclerosis	0.00209	0.0021	CcSEcCtD
Perflutren—Rash—Lovastatin—atherosclerosis	0.00208	0.00209	CcSEcCtD
Perflutren—Dermatitis—Lovastatin—atherosclerosis	0.00208	0.00209	CcSEcCtD
Perflutren—Headache—Lovastatin—atherosclerosis	0.00207	0.00208	CcSEcCtD
Perflutren—Vomiting—Ezetimibe—atherosclerosis	0.00206	0.00207	CcSEcCtD
Perflutren—Hypersensitivity—Pravastatin—atherosclerosis	0.00206	0.00207	CcSEcCtD
Perflutren—Dizziness—Simvastatin—atherosclerosis	0.00204	0.00205	CcSEcCtD
Perflutren—Rash—Ezetimibe—atherosclerosis	0.00204	0.00205	CcSEcCtD
Perflutren—Dermatitis—Ezetimibe—atherosclerosis	0.00204	0.00205	CcSEcCtD
Perflutren—Asthenia—Niacin—atherosclerosis	0.00204	0.00204	CcSEcCtD
Perflutren—Headache—Ezetimibe—atherosclerosis	0.00203	0.00204	CcSEcCtD
Perflutren—Pruritus—Niacin—atherosclerosis	0.00201	0.00202	CcSEcCtD
Perflutren—Asthenia—Pravastatin—atherosclerosis	0.002	0.00201	CcSEcCtD
Perflutren—Pruritus—Pravastatin—atherosclerosis	0.00198	0.00199	CcSEcCtD
Perflutren—Vomiting—Simvastatin—atherosclerosis	0.00196	0.00197	CcSEcCtD
Perflutren—Nausea—Lovastatin—atherosclerosis	0.00196	0.00197	CcSEcCtD
Perflutren—Rash—Simvastatin—atherosclerosis	0.00195	0.00196	CcSEcCtD
Perflutren—Dermatitis—Simvastatin—atherosclerosis	0.00195	0.00196	CcSEcCtD
Perflutren—Diarrhoea—Niacin—atherosclerosis	0.00194	0.00195	CcSEcCtD
Perflutren—Headache—Simvastatin—atherosclerosis	0.00194	0.00194	CcSEcCtD
Perflutren—Nausea—Ezetimibe—atherosclerosis	0.00192	0.00193	CcSEcCtD
Perflutren—Diarrhoea—Pravastatin—atherosclerosis	0.00191	0.00192	CcSEcCtD
Perflutren—Dizziness—Niacin—atherosclerosis	0.00188	0.00188	CcSEcCtD
Perflutren—Dizziness—Pravastatin—atherosclerosis	0.00185	0.00186	CcSEcCtD
Perflutren—Nausea—Simvastatin—atherosclerosis	0.00183	0.00184	CcSEcCtD
Perflutren—Vomiting—Niacin—atherosclerosis	0.0018	0.00181	CcSEcCtD
Perflutren—Rash—Niacin—atherosclerosis	0.00179	0.0018	CcSEcCtD
Perflutren—Dermatitis—Niacin—atherosclerosis	0.00179	0.0018	CcSEcCtD
Perflutren—Headache—Niacin—atherosclerosis	0.00178	0.00179	CcSEcCtD
Perflutren—Vomiting—Pravastatin—atherosclerosis	0.00178	0.00178	CcSEcCtD
Perflutren—Rash—Pravastatin—atherosclerosis	0.00176	0.00177	CcSEcCtD
Perflutren—Dermatitis—Pravastatin—atherosclerosis	0.00176	0.00177	CcSEcCtD
Perflutren—Headache—Pravastatin—atherosclerosis	0.00175	0.00176	CcSEcCtD
Perflutren—Nausea—Niacin—atherosclerosis	0.00168	0.00169	CcSEcCtD
Perflutren—Nausea—Pravastatin—atherosclerosis	0.00166	0.00167	CcSEcCtD
